View Older Stories

Oct 12, 2026 09:35AM RBC Capital on Mirum (MIRM): 'we could see MIRM shares up 5–10% on the EXPAND news'

Oct 12, 2026 09:34AM Baird on Mirum Pharmaceuticals (MIRM): 'we expect upside for the stock'

Oct 12, 2026 09:30AM Stifel on Mirum Pharmaceuticals (MIRM): 'We think the opportunity here remains under-appreciate'

Sep 29, 2026 06:47AM Mirum Pharmaceuticals (MIRM) PT Raised to $195 at H.C. Wainwright

Sep 28, 2026 02:02PM Mirum Pharmaceuticals (MIRM) PT Raised to $144 at Citizens

Sep 28, 2026 09:33AM Stifel Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)

Sep 14, 2026 09:43AM Citizens Reiterates Market Outperform Rating on Mirum Pharmaceuticals (MIRM)

Aug 27, 2026 04:29AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens

Aug 20, 2026 06:53AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)

Aug 6, 2026 12:59AM Mirum Pharmaceuticals, Inc. (MIRM) Misses Q2 EPS by 32c ; Offers Guidance

Jul 24, 2026 09:48AM Stifel Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)

Jul 17, 2026 05:13AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens

Jun 15, 2026 06:47AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)

Jun 15, 2026 05:20AM Mirum Pharmaceuticals (MIRM) PT Raised to $146 at Citizens After ENDO Data Reveal

Jun 4, 2026 08:06AM Mirum and Incyte to present zilurgisertib study results at ENDO 2026

Jun 2, 2026 05:01AM Citi Starts Mirum Pharmaceuticals (MIRM) at Buy

Jun 1, 2026 04:43AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens

Jun 1, 2026 02:53AM Mirum presents new data on rare liver disease treatments at EASL congress

May 19, 2026 05:33AM Wolfe Research Starts Mirum Pharmaceuticals (MIRM) at Outperform

May 7, 2026 04:28AM Mirum Pharmaceuticals (MIRM) PT Raised to $129 at Baird

May 6, 2026 04:20PM Mirum Pharmaceuticals, Inc. (MIRM) Misses Q1 EPS by 1309c ; Offers Guidance

May 4, 2026 09:41AM Baird Reiterates Outperform Rating on Mirum Pharmaceuticals (MIRM)

May 4, 2026 08:45AM Mirum Pharmaceuticals (MIRM) PT Raised to $135 at Evercore ISI

May 4, 2026 08:01AM Mirum reports volixibat meets primary endpoint in cholangitis study

Apr 28, 2026 05:05PM Mirum Pharmaceuticals (MIRM) PT Raised to $130 at Stifel

Apr 27, 2026 11:21AM Mirum Pharmaceuticals (MIRM) PT Raised to $112 at Baird

Apr 27, 2026 10:02AM Mirum Pharmaceuticals (MIRM) PT Raised to $150 at H.C. Wainwright

Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 10, 2026 08:01AM Mirum Pharmaceuticals (MIRM) Reiterated at Overweight by Cantor Fitzgerald

Mar 27, 2026 06:24AM Mirum Pharmaceuticals (MIRM) PT Raised to $125 at TD Cowen

Mar 26, 2026 04:41AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens

Mar 23, 2026 08:12AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens

Mar 17, 2026 05:30AM Citizens Reiterates Market Outperform Rating on Mirum Pharmaceuticals (MIRM)

Mar 5, 2026 09:18AM Morgan Stanley Reiterates Overweight Rating on Mirum Pharmaceuticals (MIRM) amid study enrollment, screening completion

Mar 4, 2026 08:27AM Mirum Pharmaceuticals (MIRM) PT Raised to $126 at Evercore ISI

Feb 26, 2026 10:52AM Mirum Pharmaceuticals (MIRM) PT Lowered to $118 at Leerink Partners

Feb 26, 2026 10:50AM Mirum Pharmaceuticals (MIRM) Defended by Second Outlet, This time from Evercore: 'we think the move down is noise in a volatile tape this morning.'

Feb 26, 2026 10:40AM RBC Capital Defending Mirum Pharmaceuticals (MIRM) Amid 15% Drop: 'Buying Opportunity Ahead of Multiple De-risked Catalysts'

Feb 26, 2026 04:49AM Mirum Pharmaceuticals (MIRM) PT Lowered to $132 at Citizens: Has Strong Momentum

Feb 5, 2026 08:52AM Mirum receives Health Canada approval for LIVMARLI tablet formulation

Feb 5, 2026 08:01AM Mirum Pharmaceuticals receives Health Canada approval for LIVMARLI treatment

Jan 26, 2026 06:49AM Mirum Pharmaceuticals (MIRM) PT Raised to $130 at H.C. Wainwright

Jan 15, 2026 04:16AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform: 'Top Pick' at Citizens

Jan 12, 2026 02:36PM Mirum Pharmaceuticals (MIRM) PT Raised to $95 at Baird

Jan 12, 2026 09:50AM TD Cowen on Mirum Pharmaceuticals (MIRM): 'Remain at Buy for base business and pipeline'

Jan 12, 2026 08:31AM Mirum Pharmaceuticals reports preliminary 2025 sales of $520 million

Jan 9, 2026 11:55AM Mirum launches phase 2 trial for Fragile X syndrome treatment

Dec 19, 2025 04:08PM Mirum sues generic drugmakers over Livmarli patent infringement

Dec 19, 2025 09:06AM TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'

Dec 19, 2025 04:33AM Mirum (MIRM) PT Raised to $140 at Citizens: Outperformance Expected

View Older Stories